US probes Germany over pharma pricing policies in move that could lead to new tariffs (opens original article in a new tab)

The US has launched an investigation into Germany's pharmaceutical pricing policies, which could lead to new tariffs. The probe aims to determine if Germany's practices are discriminatory and harm US commerce, with potential implications for trade relations and pharmaceutical costs.

• US initiates investigation into Germany's pharmaceutical pricing policies
• Probe could result in new tariffs on German imports
• Investigation focuses on whether Germany's pricing is discriminatory and burdens US commerce